223 related articles for article (PubMed ID: 14998310)
21. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
Dénes B
Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of goats with a combination
Leya M; Kim WK; Cho JS; Yu EC; Kim YJ; Yeo Y; Lyoo KS; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
J Vet Sci; 2018 Sep; 19(5):643-652. PubMed ID: 29929362
[No Abstract] [Full Text] [Related]
23. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
[TBL] [Abstract][Full Text] [Related]
25. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
26. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
27. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
28. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
Bugybayeva D; Kydyrbayev Z; Zinina N; Assanzhanova N; Yespembetov B; Kozhamkulov Y; Zakarya K; Ryskeldinova S; Tabynov K
Infect Dis Poverty; 2021 Feb; 10(1):13. PubMed ID: 33593447
[TBL] [Abstract][Full Text] [Related]
29. A Brucella melitensis high-temperature-requirement A (htrA) deletion mutant is attenuated in goats and protects against abortion.
Phillips RW; Elzer PH; Robertson GT; Hagius SD; Walker JV; Fatemi MB; Enright FM; Roop RM
Res Vet Sci; 1997; 63(2):165-7. PubMed ID: 9429252
[TBL] [Abstract][Full Text] [Related]
30. Brucella melitensis Rev.1 vaccination generates a higher shedding risk of the vaccine strain in Alpine ibex (Capra ibex) compared to the domestic goat (Capra hircus).
Ponsart C; Riou M; Locatelli Y; Jacques I; Fadeau A; Jay M; Simon R; Perrot L; Freddi L; Breton S; Chaumeil T; Blanc B; Ortiz K; Vion C; Rioult D; Quéméré E; Sarradin P; Chollet JY; Garin-Bastuji B; Rossi S
Vet Res; 2019 Nov; 50(1):100. PubMed ID: 31775863
[TBL] [Abstract][Full Text] [Related]
31. Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes.
Fensterbank R; Pardon P; Marly J
Ann Rech Vet; 1982; 13(4):295-301. PubMed ID: 7185320
[TBL] [Abstract][Full Text] [Related]
32. Human and animal brucellosis in Jordan between 1996 and 1998: a study.
Al-Ani FK; El-Qaderi S; Hailat NQ; Razziq R; Al-Darraji AM
Rev Sci Tech; 2004 Dec; 23(3):831-40. PubMed ID: 15861878
[TBL] [Abstract][Full Text] [Related]
33. Protective efficacy of a
Kim WK; Moon JY; Cho JS; Hur J
Can J Vet Res; 2019 Oct; 83(4):261-266. PubMed ID: 31571725
[TBL] [Abstract][Full Text] [Related]
34. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL
Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MΔvjbR strain in goats.
Castaño-Zubieta MR; Rossetti CA; García-González DG; Maurizio E; Hensel ME; Rice-Ficht AC; Ficht TA; Arenas-Gamboa ÁM
Vaccine; 2021 Jan; 39(3):617-625. PubMed ID: 33328142
[TBL] [Abstract][Full Text] [Related]
38. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
Hamdy ME; El-Gibaly SM; Montasser AM
Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
[TBL] [Abstract][Full Text] [Related]
39. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
Durán-Ferrer M; Léon L; Nielsen K; Caporale V; Mendoza J; Osuna A; Perales A; Smith P; De-Frutos C; Gómez-Martín B; Lucas A; Chico R; Delgado OD; Escabias JC; Arrogante L; Díaz-Parra R; Garrido F
Vet Microbiol; 2004 Jun; 100(3-4):219-31. PubMed ID: 15145500
[TBL] [Abstract][Full Text] [Related]
40. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
